BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240813
DTEND;VALUE=DATE:20240814
DTSTAMP:20260416T225206
CREATED:20240731T163455Z
LAST-MODIFIED:20240815T173703Z
UID:5838-1723507200-1723593599@www.immunologypodcast.com
SUMMARY:Dr. Adrian Erlebacher
DESCRIPTION:Dr. Adrian Erlebacher is a Professor in the Department of Laboratory Medicine at the University of California San Francisco. His research lies at the intersection of immunology and developmental biology. In particular\, his lab is interested in how the developmental properties of a tissue influence its ability to mount a successful immune response\, and\, conversely\, how cells of the immune system influence tissue development and remodeling. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-adrian-erlebacher
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/07/Adrian-Erlebacher-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240827
DTEND;VALUE=DATE:20240828
DTSTAMP:20260416T225206
CREATED:20240822T042356Z
LAST-MODIFIED:20240827T173454Z
UID:5866-1724716800-1724803199@www.immunologypodcast.com
SUMMARY:Dr. Kipp Weiskopf
DESCRIPTION:Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate student and demonstrated that CD47-blocking therapies could unleash immune attack against cancer and enhance a number of existing therapies. He also showed they could be used to treat small cell lung cancer and might permit bone marrow transplantation without using chemotherapy or radiation. The Weiskopf lab studies additional mechanisms that control myeloid cell activation in tumors to develop new treatments for cancer and other life-threatening diseases\, such as COVID-19.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kipp-weiskopf
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/kipp-weiskopf-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260416T225206
CREATED:20240821T230644Z
LAST-MODIFIED:20241008T204514Z
UID:5863-1727136000-1727222399@www.immunologypodcast.com
SUMMARY:Dr. Roslyn Kemp
DESCRIPTION:Dr. Roslyn Kemp is a Professor of Immunology at the University of Otago. Dr. Kemp’s research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically\, they study the role of inflammation and the unique features of different subsets of T cells and myeloid cells\, focusing on cancer and gut-specific immune responses; and how these cell subsets are involved in patient outcomes. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-roslyn-kemp
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/Roslyn-Kemp-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241008
DTEND;VALUE=DATE:20241009
DTSTAMP:20260416T225206
CREATED:20240905T185823Z
LAST-MODIFIED:20241018T181113Z
UID:5886-1728345600-1728431999@www.immunologypodcast.com
SUMMARY:Dr. Theresa Alenghat
DESCRIPTION:Dr. Theresa Alenghat is a Professor in the Immunobiology Division and Margaret K. Hostetter Chair at Cincinnati Children’s Hospital Medical Center\, University of Cincinnati. Her lab investigates mechanisms underlying the host-microbiota relationship\, and how this regulation affects intestinal immunity and inflammatory bowel disease. Dr. Alenghat has led studies revealing that epigenetics and histone deacetylases permit intestinal epithelial cells to sense commensal bacteria and convey this information to the mammalian host. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-theresa-alenghat
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/Theresa-Alenghat-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241023
DTSTAMP:20260416T225206
CREATED:20241021T005347Z
LAST-MODIFIED:20241021T005347Z
UID:5926-1729555200-1729641599@www.immunologypodcast.com
SUMMARY:Drs. Joanne Flynn and Stephen Hedrick
DESCRIPTION:Dr. JoAnne Flynn is a Professor of Microbiology & Molecular Genetics at the University of Pittsburgh. Dr. Flynn’s career has been largely focused on the immunology of tuberculosis (TB). She identified several immune factors that were involved in controlling TB and was the President of the American Association of Immunologists (AAI) from 2018-2019. \nDr. Stephen Hedrick is Chancellor’s Associates Chair VII and Distinguished Professor Emeritus at the University of California San Diego.  Dr. Hedrick is a Distinguished Fellow of AAI and was the recipient of the AAI Distinguished Service Award in 1997. He has a strong track record of eloquently advocating for childhood vaccination.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-joanne-flynn-and-stephen-hedrick
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/10/JoAnne-and-Stephen-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241105
DTEND;VALUE=DATE:20241106
DTSTAMP:20260416T225206
CREATED:20241024T184722Z
LAST-MODIFIED:20241118T181323Z
UID:5935-1730764800-1730851199@www.immunologypodcast.com
SUMMARY:Dr. Pascal Meier
DESCRIPTION:Dr. Pascal Meier is a Professor and Group Leader at the Institute of Cancer Research. His group investigates the complex relationship between cell death\, immunity and tumorigenesis. Particularly\, they focus on the role of cell death and inflammation in adaptation to tissue stress\, treatment resistance\, and tumor surveillance. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-pascal-meier
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/10/Pascal-Meier-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241120
DTSTAMP:20260416T225206
CREATED:20241104T075642Z
LAST-MODIFIED:20241104T075642Z
UID:5952-1731974400-1732060799@www.immunologypodcast.com
SUMMARY:Dr. Rahul Roychoudhuri
DESCRIPTION:Dr. Rahul Roychoudhuri is a Professor of Professor of Cancer Immunology at the University of Cambridge. His research aims to uncover the molecular and cellular mechanisms underpinning immune regulation and cancer immunosuppression. They study how T cell immunity is suppressed in cancer and Treg development and function.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-rahul-roychoudhuri
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/11/Rahul-Roychoudhuri-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241203
DTEND;VALUE=DATE:20241204
DTSTAMP:20260416T225206
CREATED:20241127T193039Z
LAST-MODIFIED:20241216T231955Z
UID:5970-1733184000-1733270399@www.immunologypodcast.com
SUMMARY:Dr. Lili Yang
DESCRIPTION:Dr. Lili Yang is a Professor of Microbiology\, Immunology\, and Molecular Genetics at the University of California\, Los Angeles. Her research centers on deciphering the molecular mechanisms regulating anti-cancer immune responses\, exploiting knowledge to develop novel immunotherapies for treating cancer\, and translating these new cancer immunotherapies from bench to bedside. Their research also extends to studying immune regulation of other chronic diseases including infections\, allergies\, and autoimmune diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-lili-yang
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/11/zLiliYang-Portrait-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250129
DTSTAMP:20260416T225206
CREATED:20240903T233235Z
LAST-MODIFIED:20250122T202050Z
UID:5883-1738022400-1738108799@www.immunologypodcast.com
SUMMARY:Dr. Erica Saphire
DESCRIPTION:Dr. Erica Saphire is a Professor\, President & Chief Executive Officer at La Jolla Institute for Immunology. Her research explains\, at the molecular level\, how and why viruses are pathogenic and provides the roadmap for medical defense. Her team has solved the structures of the Ebola\, Sudan\, Marburg\, Bundibugyo and Lassa virus glycoproteins\, explained how they remodel these structures as they drive themselves into cells\, how their proteins suppress immune function and where human antibodies can defeat these viruses.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-erica-saphire
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/09/Erica-Saphire-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250225
DTEND;VALUE=DATE:20250226
DTSTAMP:20260416T225206
CREATED:20250206T234436Z
LAST-MODIFIED:20250225T214930Z
UID:6023-1740441600-1740527999@www.immunologypodcast.com
SUMMARY:Dr. Luke O'Neill
DESCRIPTION:Dr. Luke O’Neill is a Professor and Chair of Biochemistry at Trinity College Dublin. His research group is focused on the molecular basis of inflammation\, with a particular emphasis on innate immunity and immunometabolism. They and other groups have shown that several metabolites\, such as succinate\, itaconate\, and fumarate\, and enzymes\, such as PKM2 and GAPDH play specific roles in the immune response in macrophages. They endeavor to provide a better understanding into the metabolic regulation of immune cell function and the innate immune system\, with the aim of developing novel therapies to treat inflammatory diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-luke-oneill
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/02/Luke-ONeill-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250311
DTEND;VALUE=DATE:20250312
DTSTAMP:20260416T225206
CREATED:20241217T184155Z
LAST-MODIFIED:20241217T184155Z
UID:5984-1741651200-1741737599@www.immunologypodcast.com
SUMMARY:Dr. Peter Doherty
DESCRIPTION:Dr. Peter Doherty shared the Nobel Prize in Physiology or Medicine in 1996 with Swiss colleague Rolf Zinkernagel\, for their discovery of how the immune system recognizes virus-infected cells. He was Australian of the Year in 1997\, and has since been commuting between St Jude Children’s Research Hospital in Memphis and the Department of Microbiology and Immunology at the University of Melbourne. His research is mainly in the area of defense against viruses. He regularly devotes time to delivering public lectures\, writing articles for newspapers and magazines and participating in radio discussions. \nPeter Doherty graduated from the University of Queensland in Veterinary Science and became a veterinary officer. Moving to Scotland\, he received his PhD from the University of Edinburgh Medical School. He is the first person with a veterinary qualification to win a Nobel Prize. \nPeter is also the author of several books\, including “The Beginners Guide to Winning the Nobel Prize”\, “A Light History of Hot Air”\, “Sentinel Chickens: What birds tell us about our health and the world”\, “Pandemics: What Everyone Needs to Know”\, “The Knowledge Wars” and “The incidental Tourist”.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-peter-doherty
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/12/Peter-Doherty-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250408
DTEND;VALUE=DATE:20250409
DTSTAMP:20260416T225206
CREATED:20250307T193650Z
LAST-MODIFIED:20250407T184748Z
UID:6089-1744070400-1744156799@www.immunologypodcast.com
SUMMARY:Dr. Monika Wolkers
DESCRIPTION:Dr. Monika Wolkers is a Research Group Head at the Sanquin Blood Supply Foundation and an Associate Professor at the University of Amsterdam. Dr. Wolkers’ lab investigates molecular mechanisms that define the levels of cytokine production in effector T cells and in exhausted T cells\, with a focus on post-transcriptional regulation. They aim to manipulate these mechanisms to reprogram exhausted tumor-infiltrating T cells back into proficient effector T cells.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-monika-wolkers
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/04/Monika-Wolkers-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250422
DTEND;VALUE=DATE:20250423
DTSTAMP:20260416T225206
CREATED:20250407T192512Z
LAST-MODIFIED:20250407T192512Z
UID:6093-1745280000-1745366399@www.immunologypodcast.com
SUMMARY:Dr. Henrique Veiga-Fernandes
DESCRIPTION:Dr. Henrique Veiga-Fernandes is a Full Investigator and Group Leader at the Champalimaud Foundation. \nThe Veiga-Fernandes lab studies the role of cross-talk between neurons and the immune system in the prevention and resolution of disease. They mainly focus on mucosal barriers\, such as the intestine and the lung. These organs are in permanent contact with the external environment and have a complex and dense network of neuronal and immune cells. This combination of features makes these organs an optimal site to reveal how the neural and immune systems work together to preserve health. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-henrique-veiga-fernandes
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/04/henrique-veiga-fernandes-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250505T100000
DTEND;TZID=America/New_York:20250505T111500
DTSTAMP:20260416T225206
CREATED:20250314T225300Z
LAST-MODIFIED:20250501T150545Z
UID:6066-1746439200-1746443700@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: Insights from 100 Conversations with Immunologists
DESCRIPTION:Join the Immunology Podcast for a live show at IMMUNOLOGY2025™\, as Brenda and Jason reflect on trends and perspectives in immunology\, drawing from four years of candid conversations with researchers in the field. Don’t miss this opportunity to hear behind-the-scenes stories\, ask your own questions\, and gain fresh perspectives on the future of immunology. \nDate: Monday\, May 5\, 2025\nTime: 10:00 – 11:15 a.m.\nLocation: Hawai’i Convention Center\, Room 319AB
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-insights-from-100-conversations-with-immunologists
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/05/Jason-and-Brenda-square.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250603
DTEND;VALUE=DATE:20250604
DTSTAMP:20260416T225206
CREATED:20250602T172329Z
LAST-MODIFIED:20250603T163600Z
UID:6181-1748908800-1748995199@www.immunologypodcast.com
SUMMARY:Dr. Arthur Mortha
DESCRIPTION:Dr. Arthur Mortha is an Associate Professor at the University of Toronto. His lab investigates the biology of innate lymphoid cells\, focusing on their roles in tissue immunity\, regeneration\, and interactions with non-hematopoietic cells at mucosal sites. They also explore how mononuclear phagocytes mediate immune responses to commensal microbiota.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-arthur-mortha
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/06/Arthur-Mortha-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250701
DTEND;VALUE=DATE:20250702
DTSTAMP:20260416T225206
CREATED:20250627T205559Z
LAST-MODIFIED:20250627T205559Z
UID:6201-1751328000-1751414399@www.immunologypodcast.com
SUMMARY:Dr. Mahima Swamy
DESCRIPTION:Dr. Mahima Swamy is a Programme Leader at the University of Dundee. Her main research interest is to understand how intestinal intraepithelial lymphocytes coordinate immune responses to chemical\, dietary and microbial inputs at the intestinal epithelium. They are exploring how immune homeostasis is maintained at the barrier\, and how dysregulated intraepithelial lymphocytes can be controlled.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mahima-swamy
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2025/06/Mahima-Swamy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250729
DTEND;VALUE=DATE:20250730
DTSTAMP:20260416T225206
CREATED:20250521T180723Z
LAST-MODIFIED:20250521T180723Z
UID:6172-1753747200-1753833599@www.immunologypodcast.com
SUMMARY:Dr. Tamara Tilburgs
DESCRIPTION:Dr. Tamara Tilburgs is an Assistant Professor in the UC Department of Pediatrics at Cincinnati Children’s Hospital. The Tilburgs lab investigates how maternal immune cells establish immune tolerance to fetal and placental allo-antigens and remain competent to respond to infections both systemically and in placental tissues. Their current projects are transforming the understanding of how interactions between fetal trophoblasts and maternal immune cells establish maternal fetal tolerance and immunity to infection as well as how defects in these processes may contribute to the development of pregnancy complications.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-tamara-tilburgs
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/05/Tamara-Tilburgs-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250821T160000
DTEND;TZID=America/New_York:20250821T170000
DTSTAMP:20260416T225206
CREATED:20250702T180430Z
LAST-MODIFIED:20250702T180430Z
UID:6212-1755792000-1755795600@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: The Evolution of mRNA-Based Dendritic Cell Cancer Vaccines
DESCRIPTION:Join us live from the IUIS 2025 Congress in Vienna for a special episode of the Immunology Podcast featuring Dr. Zwi Berneman\, a leader in cancer immunotherapy. In this special recording\, hosts Drs. Brenda Raud and Jason Goldsmith will guide Dr. Berneman through the two-decade evolution of mRNA-based dendritic cell vaccination\, highlighting its applications in both hematologic malignancies like acute myeloid leukemia and solid tumors such as mesothelioma and glioblastoma. Together\, they will explore the journey of scientific discovery\, clinical breakthroughs\, and real-world impact\, as Dr. Berneman reflects on the lessons learned and what the future holds for personalized immunotherapy. \nDate: Thursday\, August 21\, 2025\nTime: 4:00 – 5:00 p.m.\nLocation: Austria Center Vienna\, Hall M
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-the-evolution-of-mrna-based-dendritic-cell-cancer-vaccines
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/07/Photo_Zwi-BERNEMAN-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251008
DTSTAMP:20260416T225206
CREATED:20250826T211022Z
LAST-MODIFIED:20250826T211022Z
UID:6284-1759795200-1759881599@www.immunologypodcast.com
SUMMARY:Dr. Robin Orozco
DESCRIPTION:Dr. Robin Orozco is an Assistant Professor at the University of Kansas. Her lab uses a variety of transgenic murine models to dissect the molecular and cellular mechanisms a particular mutation is impacting viral replication\, immune cell function\, and viral associated pathologies. Currently\, they study the contribution of the common pro-autoimmune allele of PTPN22 (rs2476601) in regulating the balance between protection and pathology during virus infection.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-robin-orozco
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/08/Robin-Orozco-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251021
DTEND;VALUE=DATE:20251022
DTSTAMP:20260416T225206
CREATED:20251007T173951Z
LAST-MODIFIED:20251007T173951Z
UID:6322-1761004800-1761091199@www.immunologypodcast.com
SUMMARY:Dr. Matteo Iannacone
DESCRIPTION:Dr. Matteo Iannacone is a Professor and Group Leader at the San Raffaele Scientific Institute. The Iannacone lab’s work centers on understanding how immune responses are orchestrated within local tissue niches. Their goal is to uncover novel principles of tissue immunity and leverage them for more precise immunotherapeutic strategies.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-matteo-iannacone
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/10/Matteo-Iannacone-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251105
DTSTAMP:20260416T225206
CREATED:20251021T155701Z
LAST-MODIFIED:20251021T155701Z
UID:6339-1762214400-1762300799@www.immunologypodcast.com
SUMMARY:Dr. Camila Coelho
DESCRIPTION:Dr. Camila Coelho is an Assistant Professor at the Icahn School of Medicine at Mount Sinai\, where her group studies memory B cell responses to vaccines against emerging pathogens and novel vaccine platforms. They strive to perform impactful research that can help inform public health policies and vaccine (re)design.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-camila-coelho
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/10/Camila-Coelho-headshot.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251202
DTEND;VALUE=DATE:20251203
DTSTAMP:20260416T225206
CREATED:20251124T195333Z
LAST-MODIFIED:20251124T195333Z
UID:6363-1764633600-1764719999@www.immunologypodcast.com
SUMMARY:Dr. Ana Anderson
DESCRIPTION:Dr. Ana Anderson is the Albert H. Coons Professor of Neurology at Harvard Medical School. Research in the Anderson Laboratory focuses on understanding the pathways and mechanisms that regulate the T cell response in chronic disease\, particularly in cancer. Specific areas of investigation are examination of the role of co-inhibitory/immune checkpoint receptor pathways in regulating effector and regulatory T cells in cancer and defining the distinct effector T cell states present in tumor tissue.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-ana-anderson
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/11/Ana-Anderson-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260127
DTEND;VALUE=DATE:20260128
DTSTAMP:20260416T225206
CREATED:20260126T201253Z
LAST-MODIFIED:20260126T201253Z
UID:6402-1769472000-1769558399@www.immunologypodcast.com
SUMMARY:Dr. Rafi Ahmed
DESCRIPTION:Dr. Rafi Ahmed is a world-renowned immunologist whose work during the past decade has been highly influential in shaping our current understanding of memory T cell differentiation and anti-viral T and B cell immunity. A major area of focus is identifying cellular molecules that regulate the generation and maintenance of CD8 and CD4 T cell and humoral immunity. Another is understanding humoral memory development and maintenance.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-rafi-ahmed
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/01/Rafi-Ahmed-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260210
DTEND;VALUE=DATE:20260211
DTSTAMP:20260416T225206
CREATED:20260204T233935Z
LAST-MODIFIED:20260204T233935Z
UID:6425-1770681600-1770767999@www.immunologypodcast.com
SUMMARY:Dr. Sharon Lewin
DESCRIPTION:Dr. Sharon Lewin is the Director of the Doherty Institute for Infection and Immunity. She is an infectious diseases physician and basic scientist\, who is internationally renowned for her research into all aspects of HIV disease and specifically in strategies to achieve an HIV cure.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-sharon-lewin
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/02/Sharon-Lewin-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260225
DTSTAMP:20260416T225206
CREATED:20260204T234332Z
LAST-MODIFIED:20260204T234332Z
UID:6429-1771891200-1771977599@www.immunologypodcast.com
SUMMARY:Dr. Ido Amit
DESCRIPTION:Dr. Ido Amit is a Principal Investigator and Eden and Steven Romick Professorial Chair at the Weizmann Institute. His lab pioneered single cell genomic technologies and their application to characterize the immune system. Dr. Amit’s research answers some of the most fundamental questions in immunology which are being translated into innovate new targets for immunotherapy in autoimmune diseases\, neurodegeneration and cancer.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-ido-amit
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/02/Ido-Amit-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260417T110000
DTEND;TZID=America/New_York:20260417T120000
DTSTAMP:20260416T225206
CREATED:20260302T165757Z
LAST-MODIFIED:20260302T165757Z
UID:6457-1776423600-1776427200@www.immunologypodcast.com
SUMMARY:Live Show: Emerging Immunotherapies for Solid Tumors
DESCRIPTION:Join the Immunology Podcast for a live recording on emerging immunotherapies for solid tumors at IMMUNOLOGY2026™. Hosts Brenda Raud and Jason Goldsmith will be joined by Dr. Charles Sentman\, Director of the Center for Synthetic Immunity at Dartmouth College\, and Dr. Giulia Escobar\, Director of Pre-Clinical Research at Massachusetts General Hospital. Together\, they’ll explore new strategies aimed at overcoming the unique challenges of treating solid tumors\, from engineering more effective immune cells to navigating the tumor microenvironment. The discussion will highlight recent advances in preclinical and translational research and what they could mean for the future of cancer immunotherapy. \nDate: Friday\, April 17\, 2026\nTime: 11:00 – 12:00 pm\nLocation: Thomas M. Menino Convention & Exhibition Center\, Room 157AB
URL:https://www.immunologypodcast.com/upcoming-guests/live-show-emerging-immunotherapies-for-solid-tumors
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2026/03/Charles-Sentman-and-Giulia-Escobar.png
END:VEVENT
END:VCALENDAR